Akili Has Big Pharma Buy-In For Cognitive Disorder Video Games
This article was originally published in Start Up
Executive Summary
Alkili Interactive Labs, which is developing a video game to treat cognitive disorders, recently raised $30.5 million from PureTech, JAZZ Venture Partners and others
You may also be interested in...
Market Intel: Virtual Reality: The New Game In Mental Health Care To Improve Outcomes
Virtual reality is seeing an upsurge in use by mental health practitioners for treating conditions such as post-traumatic stress disorder, panic disorders and anxiety in a safe and controlled manner. With the advent of affordable VR headsets and technological advances, companies and researchers worldwide are seizing on the opportunity to bring such techniques as VR exposure therapy and cognitive behavioral therapy to telemedicine, specialty clinics and directly to consumers to improve outcomes and better lives.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.